Researchers have identified a new enzyme, CMLase, capable of breaking down Nε-carboxymethyl-lysine (CML), a key marker of aging and glycation damage in human tissues. While the breakthrough, detailed in Nature Communications, effectively reversed molecular markers of aging in lab-grown samples, clinical applications remain years away.
CMLase and the Reversal of Glycation Damage
Scientists have achieved a significant milestone in anti-aging research by developing an enzyme known as CMLase. The discovery, which has drawn attention in the scientific community, targets Nε-carboxymethyl-lysine (CML), an Advanced Glycation Endproduct (AGE) that accumulates in human tissues over time. Glycation occurs when sugars bind to proteins, a process long believed to be irreversible. By breaking the chemical bonds of CML, this enzyme restores proteins to their original, undamaged state.
The research team utilized a process called directed evolution
to screen more than 500 million enzyme variants to identify the specific molecule capable of dismantling CML. In laboratory tests on human skin tissue, the enzyme successfully reduced CML damage to levels typically observed in donors decades younger.
Despite the successful proof-of-concept in a laboratory setting, experts caution that consumers should not expect immediate cosmetic applications. The transition from a laboratory discovery to a commercially available product is complex. Researchers note that it will take years to figure out how to get this enzyme into the skin topically.
Furthermore, the medical community is prioritizing other applications for this technology. Because AGEs contribute to chronic inflammation and systemic conditions like atherosclerosis, these serious health concerns will likely receive research priority over anti-aging skincare products.
Comparing Aging Research to Ecological Restoration
The search for methods to reverse the effects of time is not limited to human biology. In New Zealand, a 556-acre urban ecosanctuary known as msn.com is currently implementing a 500-year plan to restore local wildlife to a pre-mammalian state. While the fields of molecular biology and ecological restoration operate on different scales, both share the goal of undoing long-term degradation.

Zealandia’s CEO, Danielle Shanahan, characterizes their aggressive predator eradication efforts as like applying a nuclear bomb
to ensure the survival of native species like the Tuatara reptile. The sanctuary, which has been operational for 26 years, serves as a proof-of-concept for habitat restoration, much as CMLase serves as a proof-of-concept for molecular repair. Both projects face the fundamental challenge of managing complex environments—whether a biological tissue matrix or a predator-plagued valley—over extended periods.
The Long-Term Outlook for AGE Research
While the technology is not yet available on store shelves, the study represents the first real evidence that damage we thought was a permanent part of aging can be repaired.
Worth a look
Discover more from Archyworldys
Subscribe to get the latest posts sent to your email.